Abstract
Transplantation of pancreatic islet cells derived from human pluripotent stem cells is a promising treatment for diabetes. Despite progress in the generation of stem-cell-derived islets (SC-islets), no detailed characterization of their functional properties has been conducted. Here, we generated functionally mature SC-islets using an optimized protocol and benchmarked them comprehensively against primary adult islets. Biphasic glucose-stimulated insulin secretion developed during in vitro maturation, associated with cytoarchitectural reorganization and the increasing presence of alpha cells. Electrophysiology, signaling and exocytosis of SC-islets were similar to those of adult islets. Glucose-responsive insulin secretion was achieved despite differences in glycolytic and mitochondrial glucose metabolism. Single-cell transcriptomics of SC-islets in vitro and throughout 6 months of engraftment in mice revealed a continuous maturation trajectory culminating in a transcriptional landscape closely resembling that of primary islets. Our thorough evaluation of SC-islet maturation highlights their advanced degree of functionality and supports their use in further efforts to understand and combat diabetes.
Pancreatic islets derived from stem cells are benchmarked against primary cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Barsby, Tom 2 ; Lithovius, Väinö 2
; Saarimäki-Vire, Jonna 2
; Omar-Hmeadi, Muhmmad 3
; Dyachok, Oleg 3 ; Montaser, Hossam 2 ; Lund, Per-Eric 3 ; Yang, Mingyu 3
; Ibrahim, Hazem 2
; Näätänen, Anna 2 ; Chandra, Vikash 2
; Vihinen, Helena 4
; Jokitalo, Eija 4
; Kvist, Jouni 2 ; Ustinov, Jarkko 2 ; Nieminen, Anni I. 5
; Kuuluvainen, Emilia 6 ; Hietakangas, Ville 7 ; Katajisto, Pekka 8
; Lau, Joey 3
; Carlsson, Per-Ola 3 ; Barg, Sebastian 3 ; Tengholm, Anders 3
; Otonkoski, Timo 9
1 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Bioinformatics and Genomics Program, Barcelona, Spain (GRID:grid.11478.3b) (ISNI:0000 0004 1766 3695); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain (GRID:grid.430579.c) (ISNI:0000 0004 5930 4623)
2 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
3 Uppsala University, Department of Medical Cell Biology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457)
4 University of Helsinki, Electron Microscopy Unit, Institute of Biotechnology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
5 Institute for Molecular Medicine Finland, Metabolomics Unit, Helsinki, Finland (GRID:grid.452494.a) (ISNI:0000 0004 0409 5350)
6 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
7 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, Molecular and Integrative Bioscience Research Program, Faculty of Biological and Environmental Sciences, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
8 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
9 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Helsinki University Hospital and University of Helsinki, Children’s Hospital, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666)





